In the last trading session, 4.04 million shares of the ENDRA Life Sciences Inc (NASDAQ:NDRA) were traded, and its beta was -0.21. Most recently the company’s share price was $3.46, and it changed around -$0.08 or -2.36% from the last close, which brings the market valuation of the company to $2.55M. NDRA currently trades at a discount to its 52-week high of $170.62, offering almost -4831.21% off that amount. The share price’s 52-week low was $2.90, which indicates that the current value has risen by an impressive 16.18% since then. We note from ENDRA Life Sciences Inc’s average daily trading volume that its 10-day average is 0.48 million shares, with the 3-month average coming to 179.16K.
ENDRA Life Sciences Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended NDRA as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
ENDRA Life Sciences Inc (NASDAQ:NDRA) trade information
Instantly NDRA has showed a red trend with a performance of -2.36% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 3.70 on recent trading dayincreased the stock’s daily price by 6.49%. The company’s shares are currently down -97.79% year-to-date, but still down -3.45% over the last five days. On the other hand, ENDRA Life Sciences Inc (NASDAQ:NDRA) is -2.90% down in the 30-day period. We can see from the shorts that 16935.0 shares have been sold at a short interest cover period of 0.4 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 76.64%.
NDRA Dividends
ENDRA Life Sciences Inc’s next quarterly earnings report is expected to be released on 2025-May-15.
ENDRA Life Sciences Inc (NASDAQ:NDRA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.10% of ENDRA Life Sciences Inc shares, and 0.15% of them are in the hands of institutional investors. The stock currently has a share float of 0.15%.
